Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

August 14, 2003

Primary Completion Date

August 30, 2007

Study Completion Date

August 30, 2007

Conditions
Lung Cancer, Non-Small CellNon-Small-Cell Lung Cancer
Interventions
DRUG

Topotecan/Docetaxel combination

DRUG

Docetaxel

Trial Locations (85)

10467

GSK Investigational Site, The Bronx

10960

GSK Investigational Site, Nyack

11030

GSK Investigational Site, Manhasset

11040

GSK Investigational Site, New Hyde Park

13057

GSK Investigational Site, East Syracuse

14623

GSK Investigational Site, Rochester

18512

GSK Investigational Site, Dunmore

19114

GSK Investigational Site, Philadelphia

20422

GSK Investigational Site, Washington D.C.

21701

GSK Investigational Site, Frederick

23502

GSK Investigational Site, Norfolk

23507

GSK Investigational Site, Norfolk

24211

GSK Investigational Site, Abingdon

27103

GSK Investigational Site, Winston-Salem

29203

GSK Investigational Site, Columbia

29303

GSK Investigational Site, Spartanburg

29926

GSK Investigational Site, Hilton Head Island

31902

GSK Investigational Site, Columbus

32073

GSK Investigational Site, Orange Park

32804

GSK Investigational Site, Orlando

33138

GSK Investigational Site, Miami Shores

33428

GSK Investigational Site, Boca Raton

33486

GSK Investigational Site, Boca Raton

33805

GSK Investigational Site, Lakeland

34994

GSK Investigational Site, Stuart

35801

GSK Investigational Site, Huntsville

36608

GSK Investigational Site, Mobile

37203

GSK Investigational Site, Nashville

37916

GSK Investigational Site, Knoxville

40207

GSK Investigational Site, Louisville

40215

GSK Investigational Site, Louisville

42101

GSK Investigational Site, Bowling Green

44718

GSK Investigational Site, Canton

46202

GSK Investigational Site, Indianapolis

48236

GSK Investigational Site, Grosse Pointe Woods

53081

GSK Investigational Site, Sheboygan

53295

GSK Investigational Site, Milwaukee

55417

GSK Investigational Site, Minneapolis

55422

GSK Investigational Site, Robbinsdale

60007

GSK Investigational Site, Elk Grove Village

60077

GSK Investigational Site, Skokie

61801

GSK Investigational Site, Urbana

62526

GSK Investigational Site, Decatur

63141

GSK Investigational Site, St Louis

65807

GSK Investigational Site, Springfield

70506

GSK Investigational Site, Lafayette

70601

GSK Investigational Site, Lake Charles

70808

GSK Investigational Site, Baton Rouge

72205

GSK Investigational Site, Little Rock

75038

GSK Investigational Site, Irving

75701

GSK Investigational Site, Tyler

80210

GSK Investigational Site, Denver

85601

GSK Investigational Site, Casper

85712

GSK Investigational Site, Tucson

89106

GSK Investigational Site, Las Vegas

89502

GSK Investigational Site, Reno

90067

GSK Investigational Site, Los Angeles

92064

GSK Investigational Site, Poway

93720

GSK Investigational Site, Fresno

98405

GSK Investigational Site, Tacoma

99204

GSK Investigational Site, Spokane

20307-5001

GSK Investigational Site, Washington D.C.

02118

GSK Investigational Site, Boston

55407-3799

GSK Investigational Site, Minneapolis

07601

GSK Investigational Site, Hackensack

14215-1199

GSK Investigational Site, Buffalo

28302-2000

GSK Investigational Site, Fayetteville

T2N 4N2

GSK Investigational Site, Calgary

E1C 8X3

GSK Investigational Site, Moncton

K7L 5P9

GSK Investigational Site, Kingston

N2G 1G3

GSK Investigational Site, Kitchener

N6A 4L6

GSK Investigational Site, London

K1H 1C4

GSK Investigational Site, Ottawa

L2R 5K3

GSK Investigational Site, St. Catharines

M5G 1X5

GSK Investigational Site, Toronto

M5G 2M9

GSK Investigational Site, Toronto

M9N 1N8

GSK Investigational Site, Weston

J4V 2H1

GSK Investigational Site, Greenfield Park

G6V 3Z1

GSK Investigational Site, Lévis

G1V 4G5

GSK Investigational Site, Sainte-Foy

25-640

GSK Investigational Site, Kielce

31-115

GSK Investigational Site, Krakow

10-228

GSK Investigational Site, Olsztyn

60-569

GSK Investigational Site, Poznan

70-891

GSK Investigational Site, Szczecin Zdunowo 20

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY